Localization, quantitation, and in situ detection of specific peptide- MHC class I complexes using a monoclonal antibody

Immunity

Volumn 6, Issue 6, 1997, Pages 715-726

  Porgador, Angel ^a   Yewdell, Jonathan W ^b   Deng, Yuping ^b   Bennink, Jack R ^b   Germain, Ronald N ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANIMAL CELL; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ARTICLE; AUTOIMMUNITY; CANCER; INFECTION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; T LYMPHOCYTE;

EID: 0030849769     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80447-1     Document Type: Article

References (55)

1. Aharoni, R., Teitelbaum, D., Arnon, R., and Puri, J. (1991). Immunomodulation of experimental allergic encephalomyelitis by antibodies to the antigen-Ia complex. Nature 351, 147-150.
2. Alam, S.M., Travers, P.J., Wung, J.L., Nasholds, W., Redpath, S., Jameson, S.C., and Garcoigne, N.R.J. (1996). T-cell-receptor affinity and thymocyte positive selection. Nature 381, 616-620.
3. al-Ramadi, B.K., Jelonek, M.T., Boyd, L.F., Margulies, D.H., and Bothwell, A.L. (1995). Lack of strict correlation of functional sensitization with the apparent affinity of MHC/peptide complexes for the TCR. J. Immunol. 155, 662-673.
4. Andersen, P.S., Stryhn, A., Hansen, B.E., Fugger, L., Engberg, J., and Buus, S. (1996). A recombinant antibody with the antigen-specific, major histocompatibility complex-restricted specificity of T cells. Proc. Natl. Acad. Sci. USA 93, 1820-1824.
5. Antón, L.C., Yewdell, J.W., and Bennink, J.R. (1997). MHC class I-associated peptides produced from endogenous gene products with vastly different efficiencies. J. Immunol., in press.
6. Ashwell, J.D., Cunningham, R.E., Noguchi, P.D., and Hernandez, D. (1987). Cell growth cycle block of T ell hybridomas upon activation with antigen. J. Exp. Med. 165, 173-194.
7. Attaya, M., Jameson, S., Martinez, C.K., Hermel, E., Aldrich, C., Forman, J., Lindahl, K.F., Sevan, M.J., and Monaco, J.J. (1992). Ham-2 corrects the class I antigen-processing defect in RMA-S cells. Nature 355, 647-649.
8. Bluestone, J.A., Jameson, S., Miller, S., and Dick, R.D. (1992). Peptide-induced conformational changes in class I heavy chains alter major histocompatibility complex recognition. J. Exp. Med. 176, 1757-1761.
9. Boon, T., and van der Bruggen, P. (1996). Human tumor antigens recognized by T lymphocytes. J. Exp. Med. 183, 725-729.
10. Brown, M.G., Driscoll, J., and Monaco, J.J. (1991). Structural and serological similarity of MHC-linked LMP and proteasome (multicatalytic proteinase) complexes. Nature 353, 355-357.
11. Catipovic, B., Dal Porto, J., Mage, M., Johansen, T.E., and Schneck, J.P. (1992). Major histocompatibility complex conformational epitopes are peptide specific. J. Exp. Med. 176, 1611-1618.
12. Chicz, R.M., Urban, R.G., Lane, W.S., Gorga, J.C., Stern, L.J., Vignali, D.A., and Strominger, J.L. (1992). Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size. Nature 358, 764-768.
13. Christinck, E.R., Luscher, M.A., Barber, B.H., and Williams, D.B. (1991). Peptide binding to class I MHC on living cells and quantitation of complexes required for CTL lysis. Nature 352, 67-70.
14. Coligan, J.E., Kruisbeek, A.M., Margulies, D.H., Shevach, E.M., and Strober, W. (1996). Current Protocols in Immunology, Volume 1 (New York: John Wiley and Sons, Inc.).
15. Corr, M., Slanetz, A.E., Boyd, L.F., Jelonek, M.T., Khilko, S., al-Ramadi, B.K., Kim, Y.S., Maher, S.E., Bothwell, A.L., and Margulies, D.H. (1994). T cell receptor-MHC class I peptide interactions: affinity, kinetics, and specificity. Science 265, 946-949.
16. Coupar, B.E.H., Andrew, M.E., and Boyle, D.B. (1988). A general method for the construction of recombinant vaccinia viruses expressing multiple foreign genes. Gene 68, 1-10.
17. Cox, J.H., Buller, M.L., Bennink, J.R., Yewdell, J.W., and Karupiah, G. (1994). Expression of adenovirus E3/19K protein does not alter mouse MHC class I-restricted responses to vaccinia virus. Virology 204, 558-562.
18. David-Watine, B., Israel, A., and Kourilsky, P. (1990). The regulation and expression of MHC class I genes. Immunol. Today 11, 286-292.
19. Demotz, S., Grey, H.M., and Sette, A. (1990). The minimal number of class II MHC-antigen complexes needed for T cell activation. Science 249, 1028-1030.
20. Due, H.T., Rucay, P., Righenzi, S., Halle-Pannenko, O., and Kourilsky, P. (1993). Monoclonal antibodies directed against T cell epitopes presented by class I MHC antigens. Int. Immunol. 5, 427-431.
21. Eastman, S., Deftos, M., DeRoos, P.C., Hsu, D.H., Teyton, L., Braunstein, N.S., Hackett, C.J., and Rudensky, A. (1996). A study of complexes of class II invariant chain peptide: major histocompatibility complex class II molecules using a new complex-specific monoclonal antibody. Eur. J. Immunol. 26, 385-393.
22. Falk, K., Rötzschke, O., Deres, K., Metzger, J., Jung, G., and Rammensee, H.G. (1991). Identification of naturally processed viral nonapeptides allows their quantitation in infected cells and suggests an allele-specific T cell epitope forecast. J. Exp. Med. 174, 425-434.
23. b. Science 257, 919-927.
24. b-ovalbumin peptide complex reveals the interplay of primary and secondary anchor positions in the major histocompatibility complex binding groove. Proc. Natl. Acad. Sci. USA 92, 2479-2483.
25. Germain, R.N. (1994). MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 76, 287-299.
26. Grandea, A.G. III, Androlewics, M.J., Athwal, R.S., Geraghty, D.E., Spies, T. (1995). Dependence of peptide binding by MHC class I molecules on their interaction with TAP. Science 270, 105-108.
27. Harding, C.V., and Unanue, E.R. (1990). Quantitation of antigen-presenting cell MHC classII/peptide complexes necessary for T-cell stimulation. Nature 346, 574-576.
28. Harlow, E., and Lane, D. (1988). Antibodies: A Laboratory Manual (Cold Spring Harbor: Cold Spring Harbor Laboratory Press).
29. Hogquist, K.A., Grandea, A.G. III, and Bevan, M.J. (1993). Peptide variants reveal how antibodies recognize major histocompatibility complex class I. Eur. J. Immunol. 23, 3028-3036.
30. Hunt, D.F., Henderson, R.A., Shabanowitz, J., Sakaguchi, K., Michel, H., Sevilir, N., Cox, A.L., Appella, E., and Engelhard, V.H. (1992). Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry. Science 255, 1261-1263.
31. Jameson, S.C., Carbone, F.R., and Bevan, M.J. (1993). Clone-specific T cell receptor antagonists of major histocompatibility complex class I-restricted cytotoxic T cells. J Exp. Med. 177, 1541-1550.
32. Karttunen, J., Sanderson, S., and Shastri, S. (1992). Detection of rare antigen-presenting cells by the LacZ T-cell activation assay suggests an expression cloning strategy for T-cell antigens. Proc. Natl. Acad. Sci. USA 89, 6020-6024.
33. Le, A.X., Bernhard, E.J., Holterman, M.J., Strub, S., Parham, P., Lacy, E., and Engelhard, V.H. (1989). Cytotoxic T cell responses in HLA-A2.1 transgenic mice: recognition of HLA alloantigens and utilization of HLA-A2.1 as a restriction element. J. Immunol. 142, 1366-1371.
34. Ljunggren, H.G., and Kärre, K. (1985). Host resistance directed against H-2-deficient lymphoma variants. J. Exp. Med 162, 1745-1749.
35. Lyons, D.S., Lieberman, S.A., Chien, Y., Berg, L.J., and Davis, M.M. (1996). A TCR binds to antagonist ligands with lower affinities and faster dissociation rates than to agonists. Immunity 5, 53-61.
36. b MHC class I molecule to alloreactive T cells. J. Exp. Med. 182, 1739-1750.
37. Matsui, K., Boniface, J.J., Reay, P.A., Schild, H., Fazekas de St. Groth, B., and Davis, M.M. (1991). Low affinity interaction of peptide-MHC complexes with T cell receptors. Science 254, 1788-1791.
38. Moore, M.W., Carbone, F.R., and Bevan, M.J. (1988). Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell 54, 777-785.
39. Munson, P.J., and Rodbard, D. (1980). LIGAND: a versatile computerized approach for characterization of ligand-binding systems. Anal. Biochem. 107, 220-239.
40. Murphy, D.B., Rath, S., Pizzo, E., Rudensky, A.Y., George, A., Larson, J.K., and Janeway, C.A. Jr. (1992). Monoclonal antibody detection of a major self peptide-MHC class-II complex. J. Immunol. 148, 3483-3491.
41. Reis e Sousa, C., and Germain, R.N. (1995). Major histocompatibility complex class I presentation of peptides derived from soluble exogenous antigen by a subset of cells engaged in phagocytosis. J. Exp. Med. 182, 841-851.
42. + T cells in response to antagonist ligands. J. Exp. Med. 184, 149-157.
43. Restifo, N.P., Bacik, I., Irvine, K.R., Yewdell, J.W., McCabe, B.J., Anderson, R.W., Eisenlohr, L.C., Rosenberg, S.A., and Bennink, J.R. (1995). Antigen processing in vivo and the elicitation of primary CTL responses. J. Immunol. 154, 4414-4422.
44. Rötzschke, O., Falk, K., Stevanovic, S., Jung, G., Walden, P., and Rammensee, H.G. (1991). Exact prediction of a natural T cell epitope. Eur. J. Immunol. 21, 2891-2894.
45. Rudensky, A., Preston, H.P., Hong, S.C., Barlow, A., and Janeway, C.A. Jr. (1991). Sequence analysis of peptides bound to MHC class II molecules. Nature 353, 622-627.
46. Sadasivan, B., Lehner, P.J., Ortman, B., Spies, T., and Cresswell, P. (1996). Roles of calreticulin and a novel glycoprotein, Tapasin, in the interaction of MHC class I molecules with TAP. Immunity 5, 103-114.
47. Schumacher, T.N., Heemels, M.T., Neefjes, J.J., Kast, W.M., Melief, C.J., and Ploegh, H.L. (1990). Direct binding of peptide to empty MHC class I molecules on intact cells and in vitro. Cell 62, 563-567.
48. b class I major histocompatibility complex (MHC) molecules to C57BL/6-and bm1-derived cytotoxic T lymphocytes: presence of a single MHC anchor residue may confer efficient peptide-specific CTL recognition. Eur. J. Immunol. 24, 2141-2149.
49. Sykulev, Y., Brunmark, A., Jackson, M., Cohen, R.J., Peterson, P.A., and Eisen, H.N. (1994). Kinetics and affinity of reactions between an antigen-specific T cell receptor and peptide-MHC complexes. Immunity 1, 15-22.
50. Sykulev, Y., Joo, M., Vturina, I., Tsomides, T.J., and Eisen, H.N. (1996). Evidence that a single peptide-MHC complex on a target cell can elicit a cytolytic T cell response. Immunity 4, 565-571.
51. Townsend, A., Öhlén, C., Bastin, J., Ljunggren, H.G., Foster, L., and Kärre, K. (1989). Association of class I major histocompatibility heavy and light chains induced by viral peptides. Nature 340, 443-448.
52. Vitello, A., Marchesinin, D., Furze, J., Sherman, L.A., and Chesnut, R.W. (1991). Analysis of the HLA-restricted-influenza-specific CTL response in transgenic mice carrying a chimeric human-mouse class I MHC. J. Exp. Med. 173, 1007-1015.
53. + T cells in the initiation of insulin-dependent diabetes mellitus. Eur. J. Immunol. 26, 1762-1769.
54. Weber, S., Traunecker, A., Oliveri, F., Gerhard, W., and Karjalainen, K. (1992). Specific low-affinity recognition of major histocompatibility complex plus peptide by soluble T-cell receptor. Nature 356, 793-796.
55. Yewdell, J.W., and Bennink, J.R. (1990). The binary logic of antigen processing and presentation to T cells. Cell 62, 203-206.